Non-healing Wound Clinical Trial
Official title:
Effect of Lidocaine and Adrenaline Soaked Gauze Versus Normal Saline Soaked at Skin Graft Donor Site of Thigh: A Randomized Control Trial
Investigator is studying the effects of Lidocaine and Adrenaline Soaked Gauze vs Normal Saline Soaked Gauze at Skin Graft Donor Site of Thigh. Haemostatic effect, epithelization and post operative pain will be assessed on follow up.
After admission participants will be randomized either to be in Group A or Group B. Closed envelop technique will be used for random assignment of the patients. Group A will be receiving 2% lidocaine and 1:100,000 adrenaline soaked gauze while group B will be given only normal saline soaked gauze at donor-site for ten minutes. The primary end point of study is intraoperative bleeding. The secondary end points of study include no. of dressings required in first 24 hours after surgery, donor site epithelization at 14th post-operative day, post-operative pain in first 24 hours after surgery along with systemic analgesia requirement after surgery. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03632031 -
Treatment of Wounds Using Oasis® ECM
|
||
Completed |
NCT03230175 -
Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01)
|
Phase 2 | |
Completed |
NCT04483934 -
Treatment of Patients With Non-healing Wounds and Trophic Ulcers Using Autologous Dermal Fibroblasts
|
Phase 1/Phase 2 | |
Terminated |
NCT04134143 -
Multiple Applications of ExpressGraft-C9T1 Skin Tissue as a Treatment for Diabetic Foot Ulcers
|
Phase 1 | |
Recruiting |
NCT04450693 -
Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)
|
Phase 3 | |
Completed |
NCT06442865 -
AMNIODERM+ Medical Device Clinical Study
|
||
Not yet recruiting |
NCT06327113 -
Antibiotic Tumescent For Chronic Wounds
|
Phase 2 | |
Not yet recruiting |
NCT03049670 -
The Use of Klorsept Solution for Debriding Infected Wounds: is it Effective and Safe? Prospective Observational Study
|
N/A | |
Not yet recruiting |
NCT05766982 -
Kerecis Fish Skin Grafts With and Without Platelet Rich Plasma (PRP)
|
N/A | |
Completed |
NCT05921292 -
Omeza Combination Therapy for the Management and Treatment of Chronic Cutaneous Wounds/Ulcers of Multiple Etiologies
|
Early Phase 1 | |
Completed |
NCT04176120 -
Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)
|
Phase 3 | |
Completed |
NCT02657876 -
ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers
|
Phase 1 | |
Not yet recruiting |
NCT06109844 -
FORCEREPAIR - A Wound Exudate Investigation
|
||
Terminated |
NCT04240574 -
Debritom - Micro Water Jet Technology and Wound Healing
|
N/A | |
Completed |
NCT05154838 -
Development of Volatile Organic Compounds (VOC) Analysis as a Potential Diagnostic for Infected and Non-Healing Wounds
|
||
Not yet recruiting |
NCT03732365 -
Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds
|
Phase 2 | |
Not yet recruiting |
NCT05251480 -
Examining the Effectiveness of DermGEN™ in the Treatment of Diabetic Foot Ulcers in First Nations People
|
N/A | |
Recruiting |
NCT05739149 -
A Study to Evaluate Microvessel Ultrasound Imaging of Wound Healing in Patients With Chronic Ulcers
|
N/A | |
Completed |
NCT03863054 -
An Observational Clinical Trial Examining the Effect of Topical Oxygen Therapy (NATROX™) on the Rates of Healing of Chronic Diabetic Foot Ulcers
|
||
Recruiting |
NCT06028386 -
Use of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers
|
N/A |